Log in
Enquire now
‌

US Patent 7972854 Methods and compositions for targeted cleavage and recombination

Patent 7972854 was granted and assigned to Sangamo Biosciences Inc. on July, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
79728540
Patent Inventor Names
Jeffrey C. Miller0
Lei Zhang0
Date of Patent
July 5, 2011
0
Patent Application Number
105877230
Date Filed
February 3, 2005
0
Patent Citations Received
‌
US Patent 11920169 Compositions for linking DNA-binding domains and cleavage domains
0
‌
US Patent 11834686 Engineered target specific base editors
0
‌
US Patent 11920148 Compositions and methods for gene editing
0
‌
US Patent 12129223 Lipids for use in lipid nanoparticle formulations
0
‌
US Patent 12122846 Chimeric antigen receptor for tumor targeting
0
‌
US Patent 11976019 Cationic lipids for use in lipid nanoparticles
0
Patent Primary Examiner
‌
Jennifer Dunston
0
Patent abstract

Disclosed herein are methods and compositions for targeted cleavage of a genomic sequence, targeted alteration of a genomic sequence, and targeted recombination between a genomic region and an exogenous polynucleotide homologous to the genomic region.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 7972854 Methods and compositions for targeted cleavage and recombination

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.